Dahlman Rose Maintains Buy on Con-way

Dahlman Rose is out with its report today on Con-way

, maintaining Buy. In a note to clients, Dahlman Rose writes, "While we are not changing our 2Q or 2011 earnings assumptions for CNW ($0.55 and $1.90 respectively), we remain confident that Con-Way, Inc. is continuing to take the correct steps to regain investor confidence in their earnings power. Accordingly, we continue to recommend shares of CNW for investors seeking exposure to the LTL sector and maintain our $44 price target." Shares of CNW closed Tuesday at $39.63, down 0.80% from Friday's close.